Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study.
Theophanous S, Lønne PI, Choudhury A, Berbee M, Dekker A, Dennis K, Dewdney A, Gambacorta MA, Gilbert A, Guren MG, Holloway L, Jadon R, Kochhar R, Mohamed AA, Muirhead R, Parés O, Raszewski L, Roy R, Scarsbrook A, Sebag-Montefiore D, Spezi E, Spindler KG, van Triest B, Vassiliou V, Malinen E, Wee L, Appelt AL; atomCAT consortium. Theophanous S, et al. Among authors: van triest b. Diagn Progn Res. 2022 Aug 4;6(1):14. doi: 10.1186/s41512-022-00128-8. Diagn Progn Res. 2022. PMID: 35922837 Free PMC article.
Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial.
Uhl M, van Triest B, Eble MJ, Weber DC, Herfarth K, De Weese TL. Uhl M, et al. Among authors: van triest b. Radiother Oncol. 2013 Feb;106(2):215-9. doi: 10.1016/j.radonc.2012.11.009. Epub 2013 Jan 16. Radiother Oncol. 2013. PMID: 23333011 Clinical Trial.
A multi-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes.
Song DY, Herfarth KK, Uhl M, Eble MJ, Pinkawa M, van Triest B, Kalisvaart R, Weber DC, Miralbell R, Deweese TL, Ford EC. Song DY, et al. Among authors: van triest b. Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):81-7. doi: 10.1016/j.ijrobp.2012.12.019. Epub 2013 Feb 13. Int J Radiat Oncol Biol Phys. 2013. PMID: 23414766 Free PMC article. Clinical Trial.
The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.
de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Sahgal A, Sarmiento JG, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Hall WA, Verkooijen HM. de Mol van Otterloo SR, et al. Among authors: van der heide ua, van triest b. Front Oncol. 2020 Sep 7;10:1328. doi: 10.3389/fonc.2020.01328. eCollection 2020. Front Oncol. 2020. PMID: 33014774 Free PMC article.
Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results.
van den Ende RPJ, Peters FP, Harderwijk E, Rütten H, Bouwmans L, Berbee M, Canters RAM, Stoian G, Compagner K, Rozema T, de Smet M, Intven MPW, Tijssen RHN, Theuws J, van Haaren P, van Triest B, Eekhout D, Marijnen CAM, van der Heide UA, Kerkhof EM. van den Ende RPJ, et al. Among authors: van der heide ua, van haaren p, van triest b. Radiat Oncol. 2020 Feb 18;15(1):41. doi: 10.1186/s13014-020-01487-6. Radiat Oncol. 2020. PMID: 32070386 Free PMC article. Clinical Trial.
Master protocol trial design for technical feasibility of MR-guided radiotherapy.
Couwenberg A, van der Heide U, Janssen T, van Triest B, Remeijer P, Marijnen C, Sonke JJ, Nowee M. Couwenberg A, et al. Among authors: van der heide u, van triest b. Radiother Oncol. 2022 Jan;166:33-36. doi: 10.1016/j.radonc.2021.11.009. Epub 2021 Nov 14. Radiother Oncol. 2022. PMID: 34785244
Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac.
Barnes H, Alexander S, Bower L, Ehlers J, Gani C, Herbert T, Lawes R, Møller PK, Morgan T, Nowee ME, Smith G, van Triest B, Tyagi N, Whiteside L, McNair H. Barnes H, et al. Among authors: van triest b. Clin Transl Radiat Oncol. 2021 Jun 29;30:31-37. doi: 10.1016/j.ctro.2021.06.003. eCollection 2021 Sep. Clin Transl Radiat Oncol. 2021. PMID: 34307911 Free PMC article.
75 results